OBJECTIVE: To study the feasibility of cardiovascular disease risk factor (CVDRF) screening at an HIV clinic in Swaziland. METHODS: A sample of HIV-positive patients at least 40 years on antiretroviral treatment was screened for hypertension, diabetes, hyperlipidemia, and tobacco smoking. RESULTS: A total of 1826 patients were screened; 684 (39%) had at least one CVDRF. Screening volume varied markedly, and was limited by staffing, space, and supplies. DISCUSSION: CVDRF screening was feasible and prevalence of risk factors in people living with HIV at least 40 years was high.
OBJECTIVE: To study the feasibility of cardiovascular disease risk factor (CVDRF) screening at an HIV clinic in Swaziland. METHODS: A sample of HIV-positivepatients at least 40 years on antiretroviral treatment was screened for hypertension, diabetes, hyperlipidemia, and tobacco smoking. RESULTS: A total of 1826 patients were screened; 684 (39%) had at least one CVDRF. Screening volume varied markedly, and was limited by staffing, space, and supplies. DISCUSSION: CVDRF screening was feasible and prevalence of risk factors in people living with HIV at least 40 years was high.
Authors: Malia Duffy; Bisola Ojikutu; Soa Andrian; Elaine Sohng; Thomas Minior; Lisa R Hirschhorn Journal: Trop Med Int Health Date: 2017-06-19 Impact factor: 2.622
Authors: Oscar H Divala; Alemayehu Amberbir; Zahra Ismail; Teferi Beyene; Daniela Garone; Colin Pfaff; Victor Singano; Harriet Akello; Martias Joshua; Moffat J Nyirenda; Alfred Matengeni; Josh Berman; Jane Mallewa; Gift S Chinomba; Noel Kayange; Theresa J Allain; Adrienne K Chan; Sumeet K Sodhi; Joep J van Oosterhout Journal: BMC Public Health Date: 2016-12-12 Impact factor: 3.295
Authors: Martin Muddu; Andrew K Tusubira; Srish K Sharma; Ann R Akiteng; Isaac Ssinabulya; Jeremy I Schwartz Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Martin Muddu; Andrew K Tusubira; Brenda Nakirya; Rita Nalwoga; Fred C Semitala; Ann R Akiteng; Jeremy I Schwartz; Isaac Ssinabulya Journal: Implement Sci Commun Date: 2020-05-04
Authors: Martin Muddu; Fred C Semitala; Isaac Ssinabulya; Simon P Kigozi; Rebecca Ssennyonjo; Florence Ayebare; Rodgers Katwesigye; Mary Mbuliro; Isaac Kimera; Chris T Longenecker; Moses R Kamya; Jeremy I Schwartz; Anne R Katahoire Journal: Implement Sci Commun Date: 2021-10-20
Authors: Kaku So-Armah; Laura A Benjamin; Gerald S Bloomfield; Matthew J Feinstein; Priscilla Hsue; Benson Njuguna; Matthew S Freiberg Journal: Lancet HIV Date: 2020-04 Impact factor: 16.070
Authors: David Sando; Alexander Kintu; Samson Okello; Peter Chris Kawungezi; David Guwatudde; Gerald Mutungi; Winnie Muyindike; Nicolas A Menzies; Goodarz Danaei; Stéphane Verguet Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 6.707
Authors: Peter Ehrenkranz; Anna Grimsrud; Charles B Holmes; Peter Preko; Miriam Rabkin Journal: J Acquir Immune Defic Syndr Date: 2021-02-01 Impact factor: 3.771